Preclinical Evaluation of a Novel PSMA-Targeted Agent <sup>68</sup>Ga-NOTA-GC-PSMA for Prostate Cancer Imaging
<b>Objectives:</b> Prostate-specific membrane antigen (PSMA)-targeted radioligands are promising diagnostic tools for the targeted positron emission tomography (PET) imaging of prostate cancer (PCa). In present work, we aimed to develop a novel PSMA tracer to provide an additional option...
Saved in:
| Main Authors: | Wenjin Li, Yihui Luo, Yuqi Hua, Qiaoling Shen, Liping Chen, Yu Xu, Haitian Fu, Chunjing Yu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-03-01
|
| Series: | Tomography |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2379-139X/11/3/29 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An Innovative Approach with [<sup>68</sup>Ga]Ga-PSMA PET/CT: The Relationship Between PRIMARY Scores and Clinical and Histopathological Findings
by: Gozde Mutevelizade, et al.
Published: (2025-07-01) -
Preclinical Evaluation of <sup>68</sup>Ga-labeled RGD Peptide for Detection of Malignant Angiogenesis
by: O. E. Klementyeva, et al.
Published: (2020-08-01) -
Preliminary clinical study of p-iodo benzoyl moiety-modified PSMA inhibitors and prospective comparison with 68Ga-PSMA-11
by: Jianpeng Cao, et al.
Published: (2025-06-01) -
USE OF <sup>177</sup>Lu-PSMA FOR RADIONUCLIDE THERAPY IN PATIENTS WITH CASTRATE-RESISTANT PROSTATE CANCER
by: A. A. Medvedeva, et al.
Published: (2021-06-01) -
<sup>225</sup>Aс-PSMA-617 therapy in metastatic castration-resistant prostate cancer
by: T. Yu. Kochetova, et al.
Published: (2025-01-01)